Physician profile
Daniel J Ross
NPI 1841724408
$16,353.23
in general payments reported to CMS, 2019-2025
19 companies · $2,270 in 2025
The $2,270 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.87 · 2022: $11K · 2023: $2,360 · 2024: $663 · 2025: $2,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,427 · Food and Beverage: $1,866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,427.35 |
| Food and Beverage | $1,865.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $12,451.16 | 2022-2025 | |
| Alon Medical Technology | $1,379.83 | 2023-2025 | |
| Stryker Corporation | $1,035.11 | 2022-2025 | Infinity Adaptis, Augment Injectable, Prostep |
| Zimmer Biomet Holdings, INC. | $406.81 | 2022 | |
| Paragon 28, INC. | $346.47 | 2022 | |
| Ossio INC | $143.80 | 2023 | |
| Depuy Synthes Sales INC. | $85.85 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $69.18 | 2024-2025 | |
| Organogenesis INC. | $68.04 | 2023 | Puraply |
| Peerless Surgical INC. | $67.87 | 2021 | |
| Kerecis Limited | $66.37 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Innovation Technologies INC | $51.99 | 2024-2025 | Irrisept |
| Smith+Nephew, INC. | $40.71 | 2023 | Ilizarov |
| Pacira Pharmaceuticals Incorporated | $31.17 | 2025 | Zilretta, Iovera, Exparel |
| Ferring Pharmaceuticals INC. | $27.78 | 2024 | Euflexxa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $26.44 | 2024 | Ethicon |
| Bioventus LLC | $23.57 | 2025 | Exogen Ultrasound Bone Healing System |
| Boston Scientific Corporation | $15.69 | 2025 | Wavewriter Alpha Prime 16 |
| Treace Medical Concepts, INC. | $15.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.